Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist administered once weekly via subcutaneous injection for weight management in adults with obesity or overweight with comorbidities
Mannervik B, Castro VM, Danielson UH, Tahir MK, Hansson J, Ringborg U
Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway
Diabetes, Obesity and Metabolism, 2017 pubmed.ncbi.nlm.nih.gov NHS: Binge eating disorder overview nhs.uk NHS: Treatment for binge eating disorder nhs.uk NICE QS175: First-line psychological treatment for binge eating disorder nice.org.uk Beat: Helplines beateatingdisorders.org.uk Aoun L, et al
1 Some common GLP-1 drugs approved by the FDA to help treat weight loss include: Semaglutide injection (Wegovy) 1 Liraglutide (Saxenda) 1 Tirezepatide (Zepbound) 1 Common Digestive Side Effects of GLP-1 Medications Gastrointestinal side effects of GLP-1 medications are not uncommon and can include: Gas (flatulence) and gas pains 1,2 Bloating 1,2 Constipation 1,2 Diarrhea 1,2 How to Manage GLP-1 Gas and Bloating Caused by Weight Loss Drugs Gas and bloating due to constipation caused by weight loss medications can be annoying (and smelly) in your daily life, but they can be easily remedied on your own
Understanding semaglutide cost with insurance is a central aspect of planning your treatment